Jun 09, 2022 / 01:30PM GMT
Brandon Couillard - Jefferies LLC, Research Division - Equity Analyst
Okay. We'll go ahead and get started. Thanks, everybody, for being here. Welcome to the Jefferies 2022 Global Healthcare Conference, back in-person. Great to see everybody, again, and thanks for being here.
I'm Brandon Couillard. I cover the Life Science Tools and Diagnostics sector. Very happy to have Repligen with us back at the conference today here and share an update on all the exciting things in the story, CFO, Jon Snodgres. Jon?
Jon K. Snodgres - Repligen Corporation - CFO
Thank you, Brandon, and good morning, everybody. It's great to see everybody. It's been 3 years since we were fortunate enough to be able to stand on the stage here and talk to you about Repligen. And a lot has happened in the last 3 years. So we've been giving you virtual updates, but I think it's great that we can get in front of you in-person today and give you a personal update.
So just getting started here. We'll jump right in. I want to walk through some of the key metrics that we have that we
Repligen Corp at Jefferies Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot